Features of occult invasion in biopsy-proven DCIS at breast MRI

Breast Journal

Volumn 19, Issue 6, 2013, Pages 650-658

  Wisner, Dorota Jakubowski ^a   Hwang, E Shelley ^b   Chang, C Belinda ^a   Tso, Hilda H ^c   Joe, Bonnie N ^a   Lessing, Juan N ^a   Lu, Ying ^d   Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c JOHN PETER SMITH HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

breast; carcinoma; ductal carcinoma in situ; invasive ductal carcinoma; invasive lobular carcinoma; kinetics; magnetic resonance imaging; signal enhancement ratio

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; CANCER DIAGNOSIS; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; RADIOLOGIST; TUMOR BIOPSY; TUMOR INVASION;

BREAST; CARCINOMA; DUCTAL CARCINOMA IN SITU; INVASIVE DUCTAL CARCINOMA; INVASIVE LOBULAR CARCINOMA; KINETICS; MAGNETIC RESONANCE IMAGING; SIGNAL ENHANCEMENT RATIO;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES;

EID: 84886797796     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12201     Document Type: Article

References (32)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C,. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275: 913-8.
2. Ernster VL, Ballard-Barbash R, Barlow WE, et al,. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002; 94: 1546-54.
3. Welch HG, Black WC,. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997; 127: 1023-8.
4. Verkooijen HM, Group CBARLCS. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002; 99: 853-9.
5. Liberman L, Drotman M, Morris EA, et al,. Imaging-histologic discordance at percutaneous breast biopsy. Cancer 2000; 89: 2538-46.
6. Ciatto S, Houssami N, Ambrogetti D, et al,. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat 2007; 101: 291-7.
7. Jackman RJ, Burbank F, Parker SH, et al,. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218: 497-502.
8. Intra M, Rotmensz N, Veronesi P, et al,. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 2008; 247: 315-9.
9. Mathew J, Agrawal A, Asgeirsson KS, et al,. Primary endocrine therapy in locally advanced breast cancers-the Nottingham experience. Breast Cancer Res Treat 2009; 113: 403-7.
10. Tan SM, Cheung KL, Willsher PC, Blamey RW, Chan SY, Robertson JF,. Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy. Eur J Cancer 2001; 37: 2331-8.
11. Hoff PM, Valero V, Buzdar AU, et al,. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. Cancer 2000; 88: 2054-60.
12. Chen Y-Y, DeVries S, Anderson J, et al,. Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer 2009; 9: 285.
13. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM,. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003; 10: 381-8.
14. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L,. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: 382-90.
15. Kuhl CK, Schrading S, Bieling HB, et al,. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007; 370: 485-92.
16. Bluemke DA, Gatsonis CA, Chen MH, et al,. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004; 292: 2735-42.
17. Berg WA, Gutierrez L, NessAiver MS, et al,. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-49.
18. Soderstrom CE, Harms SE, Copit DS, et al,. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996; 201: 427-32.
19. Huang Y-T, Cheung Y-C, Lo Y-F, Ueng S-H, Kuo W-L, Chen S-C,. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Acta Radiol 2011; 52: 1064-8.
20. Goto M, Yuen S, Akazawa K, et al,. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol 2012; 22: 1255-64.
21. Hylton NM, Blume JD, Bernreuter WK, et al,. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy-results from ACRIN 6657/I-SPY TRIAL. Radiology 2012; 263: 663-72.
22. ACR BI-RADS Committee, College of Radiology BI-RADS Committee A, College of Radiology A. ACR BI-RADS Breast Imaging and Reporting Data System: Breast Imaging Atlas. Reston VA: American College of Radiology, 2003.
23. Hylton NM,. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 1999; 7: 411-20, x.
24. Schnall MD, Blume J, Bluemke DA, et al,. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006; 238: 42-53.
25. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS,. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007; 245: 684-91.
26. Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV,. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation. Radiographics 2010; 30: 1673-87.
27. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC,. MR imaging of ductal carcinoma in situ. Radiology 1997; 202: 413-20.
28. Houssami N, Ciatto S, Ellis I, Ambrogetti D,. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007; 109: 487-95.
29. Barreau B, de Mascarel I, Feuga C, et al,. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic- pathologic correlations. Eur J Radiol 2005; 54: 55-61.
30. Ikeda DM, Hylton NM, Kinkel K, et al,. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001; 13: 889-95.
31. Swami A, Raza S, Sivarajah R, Chikarmane SA, Gautam S, Birdwell RL,. Interobserver Variability in Use of the BI-RADS Lexicon for Breast MRI. RSNA 2009 Scientific Assembly and Annual Meeting Program, SSA01-05. 2009: 292.
32. Stoutjesdijk MJ, Fütterer JJ, Boetes C, van Die LE, Jager G, Barentsz JO,. Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging. Invest Radiol 2005; 40: 355-62.